Skip to main content

Table 4 Risk factors of low birth weight

From: Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine–pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon

Variable

aCategory

LBW % (n)

Unadjusted OR (95% CI)b

Adjusted OR (95% CI)c

p-value

Setting

Semi-rural (190)

12.1 (23)

7.62 (2.59–22.52)

5.29 (1.35–16.15)

0.003

Semi-urban (79)

1.8 (4)

REF

REF

 

Age group (years)

< 21 (79)

6.3.(5)

0.6 (0.20–1.86)

0.84 (0.19–3.71)

0.822

21–25 (128)

10.2 (13)

4.38.(1.79–10.71)

2.22 (0.72–6.89)

0.166

> 25 (209)

4.3 (9)

REF

REF

 

Parity

Primiparae (122)

8.2 (10)

1.46 (0.59–3.63)

1.37 (0.39–4.83)

0.626

Secundiparae (120)

5.8 (7)

1.0 (0.37–2.70)

1.04 (0.30–3.63)

0.955

Multiparae (174)

5.8 (10)

REF

REF

 

PM infection

Positive (75)

12.0 (9)

2.45 (1.05–5.68)

2.33 (0.90–6.07)

0.083

Negative (341)

5.3.(18)

REF

REF

 

Anaemic status

Anaemic (265)

9.4 (25)

7.71 (1.8–33.02)

4.60 (1.03–20.57)

0.046

Non-anaemic (150)

1.3 (2)

REF

  

IPTp-SP dosage frequency

≥ 3 SP dose (180))

4.4 (8)

0.40 (0.16–1.0)

0.31 (0.11–0.87)

0.027

2 SP dose (140)

4.3 (6)

0.29 (0.11–0.79)

0.32 (0.11–0.93)

0.036

≤ 1 dose (96)

13.5 (13)

REF

REF

 

ITN usage

Yes (280)

6.1 (17)

1.23 (0.55–2.76)

1.15 (0.46–2.87)

0.762

No (136)

7.4 (10)

REF

REF

 
  1. PM placental malaria infection, IPTp-SP intermittent preventive treatment in pregnancy with sulfadoxine–pyrimethamine, ITN insecticide-treated nets
  2. aCounts excludes 48 women resident in Munyenge endemic foci and positive for Schistosoma haematobium
  3. bValues from confidence interval calculator
  4. cValues from multinominal regression analysis